Increasing enjoyable activities to treat depression in nursing home residents with dementia: A pilot study

This pilot study aimed to assess the feasibility and acceptability of a behavioral activities intervention (BE-ACTIV) in Australian nursing homes. BE-ACTIV was developed by researchers at the University of Louisville, USA, to improve mood and quality of life (QOL) in nursing home residents with mild to moderate dementia. An eight-week trial was conducted and 10 residents with mild to moderate dementia received the BE-ACTIV intervention while eight residents received a Walking and Talking intervention. Measures of depression (GDS-12R) and QOL (QOL-AD-NH) were administered prior to and following the interventions. Qualitative feedback indicated residents benefited from BE-ACTIV, evident by improved mood, although no statistically significant treatment effect was found. Moreover, the intervention was found to be feasible and acceptable to Australian nursing home staff and our findings highlight the importance of individualizing activities for people with dementia, of which 1:1 staff attention was a key component.

Download Full-text

Supporting autonomy of nursing home residents with dementia in the informed consent process

Dementia ◽

10.1177/1471301218761240 ◽

2018 ◽

Vol 18 (7-8) ◽

pp. 2821-2835 ◽

Cited By ~ 2

Author(s):

Elizabeth Beattie ◽

Maria O’Reilly ◽

Deirdre Fetherstonhaugh ◽

Mitchell McMaster ◽

Wendy Moyle ◽

...

Keyword(s):

Nursing Home ◽

Cognitive Impairment ◽

Informed Consent ◽

Nursing Home Residents ◽

Consent Process ◽

Cognitive Test ◽

People With Dementia ◽

Moderate Dementia ◽

Gender And Age

Background In studies involving people with dementia, researchers have historically defaulted to seeking consent from a proxy, the assumption being that people with dementia are unable to provide their own informed consent. This choice denies people with dementia a voice in the consent process, thus disregarding their autonomy and agency. Recently, other options for improving the consent process have been explored. Objective This study aimed to determine whether nursing home residents with dementia could demonstrate an ability to provide their own informed consent as determined by the Evaluation to Sign Consent instrument. Methods As part of a larger study on the quality of life of nursing home residents, the Evaluation to Sign Consent was administered to 392 people diagnosed with dementia. Data on demographic variables, such as gender and age, as well as level of cognitive impairment, were also collected. Results Just over one-fifth (22%) of the residents with dementia were judged as having the capacity to provide their own informed consent to participate in this specific research project. Consistent with existing literature, capacity to consent was significantly, and negatively, associated with cognitive impairment. Conclusion This study demonstrates that assuming all people diagnosed with dementia are unable to provide informed consent for research on the basis of cognitive test scores, or on clinical assessment alone, potentially denies them the autonomy to make a decision that they may be capable of making. Research involving people with mild-to-moderate dementia needs to consider evaluating whether potential participants have the capacity to provide their own consent.

Download Full-text

Minimum Data Set for Incontinence-Associated Dermatitis (MDS-IAD) in adults: Design and pilot study in nursing home residents

Journal of Tissue Viability ◽

10.1016/j.jtv.2018.10.004 ◽

2018 ◽

Vol 27 (4) ◽

pp. 191-198

Author(s):

Karen Van den Bussche ◽

Sofie Verhaeghe ◽

Ann Van Hecke ◽

Dimitri Beeckman

Keyword(s):

Nursing Home ◽

Pilot Study ◽

Nursing Home Residents ◽

Minimum Data Set ◽

Data Set ◽

Minimum Data

Download Full-text

Prevention and treatment of vitamin D deficiency in Dutch psychogeriatric nursing home residents by weekly half-body UVB exposure after showering: a pilot study

Age and Ageing ◽

10.1093/ageing/afq159 ◽

2010 ◽

Vol 40 (2) ◽

pp. 211-214 ◽

Cited By ~ 19

Author(s):

V. G. M. Chel ◽

M. E. Ooms ◽

S. Pavel ◽

F. de Gruijl ◽

A. Brand ◽

...

Keyword(s):

Vitamin D ◽

Nursing Home ◽

Pilot Study ◽

Vitamin D Deficiency ◽

Nursing Home Residents ◽

Prevention And Treatment ◽

Uvb Exposure

Download Full-text

Feasibility of the cognitive assessment of nursing home residents with mild-to-moderate cognitive impairment using the intelligent voice-guided digital assistant THALIE: A pilot study

Gerontechnology ◽

10.4017/gt.2020.19.04.390 ◽

2020 ◽

Vol 19 (4) ◽

pp. 1-9

Author(s):

Patricia Sagaspe ◽

Véronique Lespinet-Najib ◽

Sylvie Poulette ◽

Jean-Christophe Vasselon ◽

Amélie Roche ◽

...

Keyword(s):

Nursing Home ◽

Cognitive Impairment ◽

Pilot Study ◽

Cognitive Assessment ◽

Nursing Home Residents ◽

Moderate Cognitive Impairment

Download Full-text

TRENDS IN OPIOID USE IN LONG-TERM CARE NURSING HOME RESIDENTS WITH DEMENTIA

Innovation in Aging ◽

10.1093/geroni/igz038.2605 ◽

2019 ◽

Vol 3 (Supplement_1) ◽

pp. S709-S709

Author(s):

Hemalkumar B Mehta ◽

Yong-Fang Kuo ◽

Jordan Westra ◽

Mukaila Raji ◽

James S Goodwin

Keyword(s):

Nursing Home ◽

Long Term Care ◽

Nursing Home Residents ◽

Opioid Use ◽

Severe Dementia ◽

Term Care ◽

Dementia Patients ◽

Moderate Dementia ◽

Long Acting

Abstract We examined opioid use in long-term care nursing home residents with dementia. This retrospective cohort study used Minimum Data Set linked Medicare data, 2011-2016, and included long-term care episodes for residents 65+ years who survived 100+ days each year (592,211 episodes for 256,207 residents). Cognitive status at first annual assessment was classified as none/mild, moderate and severe impairment. Overall opioid use, prolonged opioid use (prescription supply 90+ days) and long-acting opioid use were identified from Medicare part D. Descriptive statistics were used to describe opioid use by cognitive impairment. Cochrane Armitage trends test was used to determine trends in opioid use. 114,622 (19%) patients had severe and 129,257 (22%) had moderate dementia. Overall opioid (none/mild=15.4%, moderate=13.9%, severe=9%), prolonged opioid (none/mild=5.2%, moderate=4.5%, severe=3.2%) and long-acting opioid use (none/mild=1.1%, moderate=0.9%, severe=0.3% ) were lower in patients with advanced dementia. Opioid use was significantly higher in females and Whites and varied by states. Substantial increase was found in overall opioid and prolonged opioid use from 2011 to 2016, with greater increase in none/mild and moderate dementia patients. For example, prolonged opioid use increased by 69% in none/mild and 71% in moderate dementia patients compared to 52% in severe dementia patients (p<0.0001). Long-acting opioid use decreased, with a greater decline in none/mild (69%) and moderate (71%) dementia patients compared to severe dementia patients (58%) (p<0.0001). Contrary to decreasing opioid use in community setting, overall and prolonged opioid use increased in nursing home residents. Future studies should identify the reasons behind increased use.

Download Full-text